The TDR Three Key Takeaways from Adam Goers regarding The Cannabist Company and Rescheduling Efforts: Adam Goers, Senior Vice President of Corporate Affairs at The Cannabist Company (Cboe CA: CBST, OTCQX: CBSTF),  provided detailed insights into the company’s activities and the broader cannabis regulatory environment. Speaking on the “Trade to Black” podcast this Thursday, Goers […] The post TDR Exclusive: Adam Goers Discusses Rescheduling Efforts appeared first on The Dales Report ..read more

Welcome to “Cannabis News Today,” a summary of the cannabis industry’s stock and regulatory updates. Aurora Cannabis has received expanded licenses in Germany, allowing for more cultivation and research. Profitability for the company is expected in 2026 or later, according to Wall Street estimates. Read all about it on the TDR Website! Curaleaf is opening […] The post Cannabis News Today – July 26th, 2024 appeared first on The Dales Report ..read more

The TDR Three Key Takeaways on Aurora’s Expanded Cannabis Operations in Germany: Aurora Cannabis Inc. (TSX: ACB, NASDAQ: ACB), a Canadian-based global medical cannabis company, has received expanded licenses from the Federal Institute for Drugs and Medical Devices (BfArM) under Germany’s new Medical Cannabis Act. These licenses continue Aurora’s domestic cultivation efforts and allow for […] The post Will Aurora’s Expansion in Germany Lead to Profitability? appeared first on The Dales Report ..read more

The TDR Three Key Takeaways Regarding Curaleaf Expands in New York and Earnings Estimates Curaleaf Holdings (TSX:CURA, OTC:CURLF) announced the opening of two new medical dispensaries in Rochester and Syracuse, alongside the initiation of co-located adult-use sales at existing dispensaries in Plattsburgh and Forest Hills. This expansion increases Curaleaf’s retail footprint in New York to […] The post Curaleaf Expands Dispensaries and Adult-Use Sales in NY  appeared first on The Dales Report ..read more

Welcome to “Cannabis News Today,” a summary of the cannabis industry’s stock and regulatory updates. Tilray Brands (Nasdaq: TLRY; TSX: TLRY) received approval for its third medical cannabis product, Tilray Solucao Oral THC10, in Portugal, expanding its global operations to over 20 countries. This approval comes alongside significant expansions in Germany and Australia. Read all about it on the TDR Website!                                  ..read more

The TDR Three Key Takeaways regarding LeafLink Expansion with Dama Financial Acquisition:  Integrates secure, compliant banking solutions to address cannabis operators’ financial service challenges. Enhances LeafLink’s mission as the B2B operating system for the cannabis industry, boosting efficiency and profitability. Raises Series D round from $100M to $125M, supporting growth and expanded services in the cannabis sector. LeafLink, a B2B platform in the cannabis industry, has announced its acquisition of Dama Financial’s banking division. This action by LeafLink marks a significant m ..read more

The TDR Three Key Takeaways: Local Wins for Marijuana Decriminalization in Texas: The recent dismissal of Ken Paxton’s lawsuit against San Marcos strengthens local governance over marijuana decriminalization. Ground Game Texas and Mano Amiga’s efforts have led to significant reductions in marijuana arrests, freeing resources for other public needs. Continued support for decriminalization initiatives is evident in new campaigns across multiple Texas cities. Ground Game Texas scored another victory as Judge Sherri Tibbe dismissed Ken Paxton’s lawsuit against San Marcos, reinforcing the right ..read more

The TDR Three Key Takeaways regarding Tilray Medical’s New Cannabis Product Approval: Tilray Medical receives approval for Tilray Solucao Oral THC10 in Portugal. This approval marks the third approved medical cannabis product by Tilray Medical in Portugal. The company continues to expand its global reach with operations in over 20 countries. Tilray Brands (Nasdaq: TLRY; TSX: TLRY)  announced the approval of its new medical cannabis product, Tilray Solucao Oral THC10, in Portugal. This approval is the third medical cannabis product approved by Tilray in Portugal, following approvals for ..read more

Welcome to “AI News Today,” a summary of the cannabis industry’s stock and regulatory updates. Mark Zuckerberg advocates for open-source AI, emphasizing its role in promoting innovation and safety by making technology accessible to a wider community. He argues that open source can mitigate national security risks and supports the need for balanced AI regulations that foster both innovation and security. Read all about it on the TDR Website! AI chatbots, like ChatGPT, can write fluently but often struggle with math due to their design prioritizing language prediction over rules-based calcu ..read more

Welcome to “Cannabis News Today,” a summary of the cannabis industry’s stock and regulatory updates. According to two studies, most public comments on the federal marijuana rescheduling proposal support full de-scheduling rather than rescheduling it to Schedule III. The public’s record of participation shows a strong demand for comprehensive federal marijuana reform to address racial justice and social equity. Read all about it on the TDR Website! Dallas voters will decide in November whether to adopt the “Dallas Freedom Act,” which aims to decriminalize marijuana possession and limit poli ..read more